Cell-type specific molecular and functional analyses to target dorsal horn pain circuitry in mice and non-human primates

针对小鼠和非人类灵长类动物背角疼痛回路的细胞类型特异性分子和功能分析

基本信息

项目摘要

Project Summary Persistent pain remains a major clinical problem because of its high prevalence and the lack of adequate treatment options. The spinal dorsal horn is a major site for the integration of somatosensory information and for circuit-based transformations that underlie persistent pain. The overall goal our work is to develop novel pain therapies that target the dorsal horn circuitry for mechanical allodynia. We use cell type-specific targeting of chemogenic receptors to identify spinal dorsal horn neurons that mediate mechanical allodynia without affecting acute sensation in mice. Mice are a commonly used model system for these studies because of their general similarity to humans, the ease of genetic manipulations and the large number of tools available. However, targeting spinal dorsal horn neurons for therapeutic purposes requires an understanding of the cellular and molecular conservation between species. Rhesus macaque are phylogenetically more similar to humans and with re-engineered tools can serve as a proof-of- principle model system. To this end, we analyzed the molecular and cellular organization of the macaque dorsal horn by single cell transcriptomics and in situ hybridization methods. We compared these data to mouse and human data to generate a harmonized atlas of dorsal horn cell types across species. Here we will 1) Identify the epigenetic landscape of human, macaque and mouse dorsal horn neurons using single nucleus RNA- and ATAC-Seq data together with machine learning-assisted bioinformatic approaches to identify regulatory elements (REs) that drive robust cell type-specific gene expression across species. We will 2) screen candidate REs for cell-type specificity in mice and subsequently macaque and then use the cell type-specific REs to systematically generate a functional map of the dorsal horn across species. Studies proposed here will generate large-scale searchable databases for single cell transcriptomics and open chromatin regions in mice, macaque and human. Importantly, we will have the knowledge and viral vectors needed to pursue macaque proof-of-principle studies of novel therapies for mechanical allodynia.
项目摘要 持续性疼痛仍然是一个主要的临床问题,因为它的高患病率和缺乏治疗。 充足的治疗选择。脊髓背角是整合的主要部位, 躯体感觉信息和基于电路的转换,构成持续性疼痛的基础。 我们工作的总体目标是开发针对背角回路的新型疼痛疗法 治疗机械性异常性疼痛我们使用细胞类型特异性靶向化学受体, 脊髓背角神经元介导机械性异常性疼痛而不影响急性感觉 对小鼠小鼠是这些研究中常用的模型系统,因为它们的一般特性, 与人类的相似性,基因操作的容易性和大量可用的工具。 然而,靶向脊髓背角神经元用于治疗目的需要一种方法, 了解物种之间的细胞和分子保守性。恒河猴是 在遗传学上与人类更相似,并使用重新设计的工具可以作为证据- 原理模型系统为此,我们分析了细胞的分子和细胞组织, 用单细胞转录组学和原位杂交方法研究猕猴背角的细胞凋亡。我们 将这些数据与小鼠和人类数据进行比较,以生成协调的背角图谱 不同种类的细胞。在这里,我们将1)确定人类,猕猴, 和小鼠背角神经元使用单核RNA-和ATAC-Seq数据连同 机器学习辅助的生物信息学方法来识别调控元件(RE), 驱动跨物种的强大细胞类型特异性基因表达。我们将2)筛选候选RE 用于小鼠和随后的猕猴中的细胞类型特异性,然后使用细胞类型特异性RE 来系统地绘制出不同物种的背角的功能图。拟议的研究 这里将为单细胞转录组学产生大规模可搜索数据库, 小鼠、猕猴和人类的染色质区域。重要的是,我们将拥有知识, 病毒载体需要进行猕猴原理验证研究的新疗法 机械性异常性疼痛

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Andreas Robert Pfenning其他文献

Andreas Robert Pfenning的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Andreas Robert Pfenning', 18)}}的其他基金

Interpreting the regulatory mechanisms underlying the predisposition to substance use disorders
解释物质使用障碍倾向背后的调节机制
  • 批准号:
    10187538
  • 财政年份:
    2018
  • 资助金额:
    $ 49.91万
  • 项目类别:
Interpreting the regulatory mechanisms underlying the predisposition to substance use disorders
解释物质使用障碍倾向背后的调节机制
  • 批准号:
    10434023
  • 财政年份:
    2018
  • 资助金额:
    $ 49.91万
  • 项目类别:
Interpreting the regulatory mechanisms underlying the predisposition to substance use disorders
解释物质使用障碍倾向背后的调节机制
  • 批准号:
    9764328
  • 财政年份:
    2018
  • 资助金额:
    $ 49.91万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 49.91万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 49.91万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 49.91万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 49.91万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 49.91万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 49.91万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 49.91万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 49.91万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 49.91万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 49.91万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了